News

Islet has licensed technology from the University of California to commercialize an invention for expanding pancreatic islets. Islet Sciences chief scientific officer Dr. Jonathan Lakey said in the

Lewis has also been appointed to the company’s board of directors and succeeds Tim Whitten, who resigned as president and chief executive officer and as a company’s board

Hisun-Pfizer is expected to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets. The registration facilities and production plants of the joint venture will be

The €75m Yaroslavl facility will initially manufacture Cardiomagnyl, Actovegin and Calcium tablets to meet the Russian demand. The 24,000m² facility will also manufacture 90 million sterile ampoules and

The pipetting system with ClipTip interlocking technology will lock tips securely into place to deliver an airtight seal on every channel. Thermo Fisher liquid transfer product director Raymond

The companies will discover, select, screen and synthesize compounds for targets that are of specific interest to major pharmaceutical companies. As part of the agreement, COTI will utilise

TNIB, as part of its obligations under existing contracts as well as those under negotiation reached an agreement with MOV-FAS, will finance and construct a plant to produce

Creative Edge Nutrition CEO Bill Chaaban said the acquisition is part of Creative Edge Nutrition’s expansion plan in the online supplement superstore field. ”With a team that has

The technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences has licensed last month. Islet Sciences chairman and CEO John Steel said in the